Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Financings In Brief

This article was originally published in The Gray Sheet

Executive Summary

Cutera IPO: CoolGlide aesthetic laser manufacturer will use $15 mil. of the expected $38.7 mil. in net proceeds to expand its 40-person sales & marketing team, according to a March 30 1prospectus filed with SEC. Roughly $5 mil. is earmarked for R&D, and the rest will go to "general corporate purposes." Piper Jaffray is lead underwriter for the IPO, which is offering 3.5 mil. shares of Cutera common stock at $14; SG Cowen and RBC Capital Markets are co-managers. The firm intends to trade on Nasdaq under the symbol "CUTR." Cutera, formerly Altus Medical, first filed to go public in January 2002, but later abandoned the attempt (2"The Gray Sheet" Jan. 28, 2002, p. 17). In Q1 alone, other device and diagnostic firms opting to go public included Digirad, Immunicon, NuVasive, Angiodynamics, Kinetic Concepts, Animus and Novacept...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT020010

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel